Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.37
-0.03 (-0.15%)
At close: Aug 10, 2026, 4:00 PM EDT
20.30
-0.07 (-0.34%)
After-hours: Aug 10, 2026, 7:34 PM EDT

Syndax Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-220.77-285.42-318.76-209.36-149.3424.93
Depreciation & Amortization
0.020.010.010.010.030.04
Stock-Based Compensation
49.447.543.0330.9516.0213.32
Other Adjustments
-4.28-5.75-12.45-14.06-2.050.44
Change in Receivables
-25.61-30.39-7.6---
Changes in Inventories
-15.2-32.09-0.37---
Changes in Accounts Payable
-12.484.951.675.61-1.322.16
Changes in Accrued Expenses
17.2242.1719.1414.879.422.77
Changes in Unearned Revenue
------13.13
Changes in Other Operating Activities
-13.32-63.49-0.0311.38-6.45-1.39
Operating Cash Flow
-220.64-322.98-274.9-160.6-133.6829.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.19-0.19----0.13
Sale of Property, Plant & Equipment
----0.23-
Purchases of Investments
-218.82-195.81-557.05-354.61-495.35-294.72
Proceeds from Sale of Investments
394.53486.03337.28472.22308.93253.98
Investing Cash Flow
175.48290.04-219.78117.61-186.19-40.87

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-----21-
Net Long-Term Debt Issued (Repaid)
-----21-
Issuance of Common Stock
29.0413.68353.37264.13193.25117.89
Net Common Stock Issued (Repurchased)
29.0413.68353.37264.13193.25117.89
Other Financing Activities
-----0.58
Financing Cash Flow
272.8813.68353.37264.13172.25118.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
227.73-19.27-141.31221.14-147.61106.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-220.83-323.17-274.9-160.6-133.6829
Free Cash Flow Growth
------
FCF Margin
-87.54%-187.50%-1160.91%--20.76%
Free Cash Flow Per Share
-2.51-3.73-3.21-2.28-2.200.54
Levered Free Cash Flow
-244.72-334.06-298.34-177.49-168.6515.24
Unlevered Free Cash Flow
-218.13-321.73-319.26-198.08-150.0716.54
SEC Filings: 10-K · 10-Q